Resources from the same session
Strategies for overcoming EGFR resistance in NSCLC patient management
Presenter: Antonio Passaro
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast
Expanding our horizons: Novel frontline approaches in EGFR-mutant NSCLC
Presenter: Nicolas Girard
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast
Current and future directions for EGFR exon 20 insertion mutations in NSCLC
Presenter: Joshua Sabari
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast
Key learnings/closing remarks
Presenter: Natasha Leighl
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast